Mark Egerton

Examiner
DISC Type : cs

Non Executive Chairman at Panthera Biopartners

United Kingdom

Overview

A board-level executive with over 35 years of experience in the pharmaceutical industry, from large multinationals to emerging biotech. Holding a PhD from The University of Edinburgh, he has a strong record of blending scientific training with commercial leadership, notably during his 18 years as CEO of Quotient Sciences.

He is passionate about creating high-performing teams to translate high-impact science and technology into tangible value for patients, employees, and shareholders. His current focus is on providing strategic guidance and leadership in non-executive and advisory capacities.

After a successful 18-year tenure as CEO, he consciously decided to retire from full-time executive life to contribute his expertise as a chairman and advisor.

Personality Overview

Process Oriented

Late Adopter

Status Quo Seeker

Being observant comes to them naturally.  They do not like taking risks at all and go for proven options in the end. They are thorough and always follow a systematic approach.

Topics They Care About

Drug Development
With over 35 years in the pharmaceutical industry and 18 years as CEO of a services provider, he has deep expertise in the development lifecycle.
Corporate Leadership
Successfully led Quotient Sciences as CEO for nearly two decades and now holds multiple Non-Executive Chairman and Board Advisor positions.
Scientific Innovation
Holds a PhD in Neuropharmacology and is passionate about translating high-impact science and technology into real-world value for patients.

Media Appearances

Mark Egerton Appointed Chairman of Panthera Biopartners. Featured in PharmiWeb.com

See Now

Panthera BioPartners Appoints Mark Egerton as Chairman. Featured in PharmaFocus America

See Now

Mark Egerton Appointed Chairman of Panthera Biopartners. Featured in PharmiWeb.com

See Now

Work History

8-2025
Non Executive Chairman at Panthera Biopartners
7-2025
Non Executive Chairman at Newmarket Strategy
4-2025
Board Advisor at QbD Group
5-2024
Principal at Edgy Advisory Ltd
9-2005 - 10-2023
Chief Executive Officer at Quotient Sciences

Education

1985 - 1988
PhD from The University of Edinburgh
1982 - 1985
BSc from University of Leicester

More Information

Social Presence :

Prographics :

Exp : 20 Location : United Kingdom Job Level : N/A Designation : Non Executive Chairman at Panthera Biopartners
URL has been copied!

Insights For Selling To Mark

During A Call Or A Meeting

DO's

  • Spend time addressing concerns around risk and change, they will have them even if they don't express them
  • Be firm in your communication and stay in control
  • Expect them to be slow and cautious, encourage them to ask more questions

DONT's

  • Avoid getting into storytelling mode, especially when they ask specific questions
  • Don't use phrases like 'do not worry', 'i promise' etc.
  • Don't push them too hard to make fast decisions, give them time

When Cold Calling

When Writing An Email

While Negotiating & Closing

    The secret to closing fast with Mark is

  • Low-risk, adoption by others are very important to them, followed by confidence in ROI.
  • Will you ever get a clear answer from Mark

  • Often, they don't say no, or keep going about it in circles.

Insights For Deal Planning

    How fast (or slow) will Mark move?

  • They do not like to rush and therefore can be quite slow in their decision-making.
  • Can Mark take some risk or not?

  • They have little risk-appetite and prefer to take measured decisions.

You And Mark

Personality Compatibility


More Profiles

Discover additional public profiles from our index.

Search more profiles

Looking for someone else? Search here for anyone.

Or visit Humantic AI to know more.